SERVICIO CANARIO DE LA SALUD

Their core work

The Canary Islands Health Service is the public healthcare system of Spain's Canary Islands, operating hospitals and research units across the archipelago. In H2020, they contributed clinical expertise in vestibular disorders and chronic disease prevention, coordinating work on bionic vestibular implants and participating in AI-driven health risk prediction. Their research spans from niche neurostimulation prosthetics to broader population health economics and digital health tools for chronic condition management.

What they specialise in

How they've shifted over time

With only three projects spanning 2018–2025, the evolution is modest but traceable. Their earliest engagements (2018) covered health economics (PECUNIA) and vestibular bionics (BionicVEST), combining clinical service delivery expertise with niche surgical device research. By 2021 they moved toward digital health and AI with WARIFA, suggesting a shift from purely clinical and biomedical research toward data-driven, person-centered prevention approaches.

Moving from specialized biomedical device research toward digital health and machine learning applications for population-level chronic disease prevention.

How they like to work

They split their roles between coordination (BionicVEST) and participation, showing capacity to both lead and contribute. With 29 unique partners across 13 countries from just 3 projects, they work in medium-to-large European consortia rather than small bilateral teams. This indicates openness to broad international collaboration, though their limited project count means they are not yet a well-established consortium hub.

Despite only three projects, they have built connections with 29 partners across 13 countries, reflecting participation in well-networked European consortia. Their geographic spread is broad for a regional health service, with no obvious clustering beyond Spain.

What sets them apart

As a regional public health service (not a university or dedicated research institute), they bring real clinical infrastructure and patient access to research consortia — something pure research labs cannot offer. Their coordination of BionicVEST shows they can lead ambitious biomedical device projects, not just provide clinical trial sites. For consortium builders, they offer a rare combination: a public healthcare operator with hands-on research ambition in niche areas like vestibular rehabilitation and digital prevention tools.

Highlights from their portfolio

• BionicVEST
  Their flagship project as coordinator (EUR 728K) — developing a bionic vestibular implant, an unusual and highly specialized medical device topic for a regional health service.
• WARIFA
  Marks their pivot to AI and machine learning in health, applying person-centered digital tools to chronic disease risk factors.